Furthermore, using a population of 681 glioma patients from the CGGA data, we verified that EZH2 expression is related to a poor overall survival25 and demonstrated the predictive ability of EZH2 expression by performing ROC analysis. This evidence concerns the gene EZH2 and central nervous system cancer.